Colonial River Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
3,965
+557
+16% +$73.4K 0.14% 128
2026
Q1
$475K Sell
3,408
-308
-8% -$43.1K 0.17% 132
2025
Q4
$456K Sell
3,716
-293
-7% -$35.6K 0.16% 137
2025
Q3
$445K Buy
4,009
+708
+21% +$80.5K 0.16% 136
2025
Q2
$378K Buy
3,301
+1,172
+55% +$125K 0.16% 138
2025
Q1
$239K Sell
2,129
-985
-32% -$102K 0.13% 166
2024
Q4
$288K Sell
3,114
-193
-6% -$17.4K 0.14% 146
2024
Q3
$277K Sell
3,307
-8,948
-73% -$683K 0.14% 161
2024
Q2
$841K Buy
12,255
+1,070
+10% +$71.4K 0.45% 64
2024
Q1
$819K Buy
11,185
+6,983
+166% +$537K 0.46% 63
2023
Q4
$340K Buy
+4,202
New +$327K 0.2% 132
2023
Q2
Sell
-2,626
Closed -$218K 181
2023
Q1
$218K Sell
2,626
-68
-3% -$5.63K 0.13% 181
2022
Q4
$231K Buy
+2,694
New +$213K 0.15% 162

Other funds holding GILD

Colonial River Investments's GILD Position: Q2 2026 in Review

Colonial River Investments increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $73.4K and bringing the position to 3,965 shares worth $501K. The position accounts for 0.14% of the portfolio, ranked #128.

Colonial River Investments first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $841K in Q2 2024. 1,323 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Colonial River Investments held 3,965 shares of Gilead Sciences worth $501K as of Q2 2026.
  • Colonial River Investments bought 557 Gilead Sciences shares in Q2 2026, an estimated $73.4K.
  • Gilead Sciences made up 0.14% of Colonial River Investments's portfolio in Q2 2026, its #128 holding.
  • Colonial River Investments first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • Colonial River Investments's Gilead Sciences position peaked at $841K in Q2 2024.
  • 1,323 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.